Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.
Journal: Circulation
Published: September 11, 2013
Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).
Journal: The American journal of cardiology
Published: August 14, 2013
Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Journal: Journal of the American College of Cardiology
Published: January 10, 2013
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
Journal: Circulation
Published: December 29, 2012
Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
Journal: Circulation
Published: October 03, 2012
Subclinical atrial fibrillation and the risk of stroke.
Journal: The New England journal of medicine
Published: January 13, 2012
Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
Journal: Circulation
Published: January 05, 2012
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
Journal: Annals of internal medicine
Published: November 16, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026